Breaking News
February 17, 2019 - MUSC researchers discover new mechanism for a class of anti-cancer drugs
February 17, 2019 - HPV misconceptions are causing women to miss smear tests
February 17, 2019 - Sanofi and Regeneron Offer Praluent (alirocumab) at a New Reduced U.S. List Price
February 17, 2019 - Researchers say auditory testing can identify children for autism screening
February 17, 2019 - New method analyzes how single biological cells react to stressful situations
February 17, 2019 - WVU gynecologic oncologist investigates novel treatment for cervical and vaginal cancers
February 17, 2019 - ADHD diagnoses poorly documented
February 17, 2019 - Majority of gender minority youth do not identify with traditional sexual identity labels
February 17, 2019 - AbbVie, Teneobio enter into strategic transaction to develop potential treatment for multiple myeloma
February 17, 2019 - Lower Birth Weight May Up Risk for Psychiatric Disorders
February 17, 2019 - Scientists identify reversible molecular defect underlying rheumatoid arthritis
February 17, 2019 - Moffitt researchers shed light on how CAR T cells function mechanistically
February 16, 2019 - Female Anatomy May Play Big Role in Sperm’s Success
February 16, 2019 - BMI may mediate inverse link between fiber intake, knee OA
February 16, 2019 - Movement impairments in autism can be reversed through behavioral training
February 16, 2019 - Studies address racial disparities in postpartum period and cardiovascular health
February 16, 2019 - Scientists implicate hidden genes in the severity of autism symptoms
February 16, 2019 - Decreased deep sleep linked to early signs of Alzheimer’s disease
February 16, 2019 - Neuroscientists show how the brain responds to texture
February 16, 2019 - Gilead Announces Topline Data From Phase 3 STELLAR-4 Study of Selonsertib in Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)
February 16, 2019 - What Can I Do About Sweating? (for Teens)
February 16, 2019 - Companies navigate dementia conversations with older workers
February 16, 2019 - Newly developed stem cell technologies show promise for treating PD patients
February 16, 2019 - Collaborative material research could advance self-assembling nanomaterials
February 16, 2019 - Researchers take major step in creating technology that mimics the human brain
February 16, 2019 - Erasing memories associated with cocaine use reduces drug seeking behavior
February 16, 2019 - Artificial intelligence can accurately predict prognosis of ovarian cancer patients
February 16, 2019 - Racial disparities in cancer deaths on the decline for America
February 16, 2019 - FDA authorizes new interoperable insulin pump for children, adults with diabetes
February 16, 2019 - Coexisting Medical Conditions, Smoking Explain PTSD-CVD Link
February 16, 2019 - Skin Cancer Screening: MedlinePlus Lab Test Information
February 16, 2019 - ‘Happiness’ exercises can boost mood in those recovering from substance use disorder
February 16, 2019 - Cell manipulation could soon halt or reverse aging
February 16, 2019 - Pumped Breast Milk Falls Short of Breastfed Version
February 16, 2019 - Men’s porn habits could fuel partners’ eating disorders, study suggests
February 16, 2019 - Rapid progression of age-related diseases may result from formation of vicious cycles
February 16, 2019 - Immune checkpoint molecule protects against future development of cancer
February 16, 2019 - New method produces hydrogels that have properties similar to cells’ environment
February 16, 2019 - $4.1 million funding for heart research on Valentine’s Day
February 16, 2019 - General anesthesia in early infancy unlikely to have lasting effects on developing brains
February 16, 2019 - New breakthroughs for muscular dystrophy research
February 16, 2019 - First Opinion: Embryo editing for higher IQ is a fantasy. Embryo profiling for it is almost here
February 16, 2019 - Vapers develop cancer-related gene deregulation as cigarette smokers
February 16, 2019 - Bringing Antimicrobial Susceptibility Testing (AST) to the Community
February 16, 2019 - Decolonization protocol after hospital discharge can prevent dangerous infections
February 16, 2019 - Children with ASD more likely to face maltreatment, study finds
February 16, 2019 - Study finds genetic vulnerability to use of menthol cigarettes
February 16, 2019 - H-RT should be the standard of care for men with low risk prostate cancer, study shows
February 16, 2019 - New technique using patients’ own modified cells could help treat Crohn’s disease
February 16, 2019 - Therapeutic endoscopy has an expanding role in the treatment of IBD
February 16, 2019 - Blood clot discovery could lead to development of better treatments for blood diseases
February 16, 2019 - Intervention can increase exclusive breastfeeding rates
February 16, 2019 - New project explores how gaming technologies can help cancer patients communicate better
February 16, 2019 - Catalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors at the 12th Annual EAHAD Congress
February 16, 2019 - Rerouting nerves during amputation reduces phantom limb pain before it starts
February 16, 2019 - A Hormone Produced When We Exercise Might Help Fight Alzheimer’s
February 16, 2019 - Millions of British people breathe toxic air travelling to GPs
February 16, 2019 - Conformance of genetic characteristics found to be crucial for longer preservation of kidney graft
February 16, 2019 - Researchers use optogenetic tool to control, visualize receptor signals in neural cells
February 16, 2019 - New reversible antiplatelet therapy could reduce risk of blood clots, prevent cancer metastasis
February 16, 2019 - Testosterone is not the only hormone needed for penis development
February 16, 2019 - FDA Advisory Committee Recommends Approval of Spravato (esketamine) Nasal Spray for Adults with Treatment-Resistant Depression
February 15, 2019 - Heart surgery technology developed at Baptist Health debuts after years of secrecy
February 15, 2019 - Prescription Opioids Double Risk of Triggering Fatal Car Crash
February 15, 2019 - New study helps doctors better understand high blood pressure in pregnant women
February 15, 2019 - Beta wave control in Parkinson’s diseased brain could be a potential therapy
February 15, 2019 - Media representations of love may justify gender-based violence in young people
February 15, 2019 - Yoga May Help With Rheumatoid Arthritis Symptoms, Severity
February 15, 2019 - Obstructive sleep apnea linked to inflammation, organ dysfunction
February 15, 2019 - Master your mind: A challenge from WELL for Life
February 15, 2019 - Why Some Brain Tumors Respond to Immunotherapy
February 15, 2019 - Must-Reads Of The Week From Brianna Labuskes
February 15, 2019 - Researchers uncover novel mechanism and potential new therapeutic target for Alzheimer’s
February 15, 2019 - Genetic variations in a fourth gene associated with higher ALL risk in Hispanic children
February 15, 2019 - Disruptive behavioral problems in kindergarten linked with lower employment earnings in adulthood
February 15, 2019 - New bioengineered device enhances the production of T-cells
February 15, 2019 - HDL proteome behaves like a tiny Velcro ball that is rolling on surfaces
February 15, 2019 - Puerto Rican children more likely to have poor or decreasing use of asthma inhalers
February 15, 2019 - Quality of patient care does not improve after physician-hospital integration
February 15, 2019 - Synopsys release new software for implant design and patient-specific planning
Understanding How Antibodies Shape the Gut Microbiome

Understanding How Antibodies Shape the Gut Microbiome

image_pdfDownload PDFimage_print

What function does IgA carry out in the human immune system?

IgA is the most abundant class of immunoglobulin in the human body, with an estimated 80% of the total plasma cells in our body being IgA+.

Image Credit: Kateryna Kon / Shutterstock

Secretory IgA plays an important role as a frontline defense against pathogen invasion, and also to neutralize toxins and viruses.

Our previous studies extended this classic view by finding a role for IgA in the maintenance of commensal gut microbiota.

By using genetically modified mice, we showed that IgA-deficiency caused the expansion of certain members of commensal bacteria in the gut.

Thus, IgA is functioning not only to protect us from harmful pathogens but also to maintain the commensal gut microbiota in mice and humans.

Why is it important to study how antibodies affect the microbiome?

Gut microbiota are essential for many aspects of our health, and a disturbed microbiome can cause many diseases such as obesity, autoimmune diseases and colitis.

Understanding the mechanisms behind the maintenance of a “healthy” microbiota in the gut may lead to the development of new methods for the treatment or prophylaxis of diseases.

Bacteria in the gut microbiomeImage Credit: Anatomy Inside / Shutterstock

Our body consumes a lot of energy to generate large amounts of gut IgA, but very little is known about how the IgA interacts with commensal microbiota to induce beneficial effects for the host.

This system is very complex, considering the heterogeneity of the IgA repertoire and also the diversity of the gut microbiota both in composition and metabolic function.

To understand the mechanisms involved in the maintenance of gut homeostasis, we need to dissect this complexity, and the study of the interaction between IgA and the microbiome plays a major role in this.

Please describe your recent research.

We recently proved that IgA antibodies promote the growth of beneficial bacteria in the gut of a mouse model.

Firstly, in order to eliminate IgA-heterogeneity, we developed monoclonal IgA that recognizes OVA protein (7-6IgA). We found that the 7-6IgA was heavily glycosylated and bound on the surfaces of many bacteria independent of the antigen recognition site of the antibody.

Among the bacteria strains we tested, Bacteroides thetaiotaomicron (B.theta) – a prominent human gut microbiota – had the highest capacity to bind on the glycosylated 7-6IgA.

We next developed a mouse system in which 7-6IgA was the only gut IgA, and concomitantly colonized it with B. theta.

In the cecum of these mice, the gene expression profile of B. theta was significantly altered including the up-regulation of a functionally uncharacterized operon. We provisionally named this operon Mucus-Associated Functional Factor (MAFF).

Interestingly,  MAFF expression in vivo was induced only under the presence of diverse microbiota but not in mono-colonized mice, indicating that the function of this operon requires interaction with other bacterial members.

We observed that symbiotic bacteria belonging to phylum Firmicutes expanded under the function of the MAFF system and in the presence of IgA, showing that IgA and the MAFF system plays a critical role in symbiotic interactions between these bacterial members.

Finally, we applied chemically induced colitis to the B. theta colonized mice. Surprisingly, we found that the mice colonized with the MAFF-deletion mutant of B. theta quickly died from severe colitis, but those mice colonized with wild-type B. theta were protected from the colitis.

This was due to the metabolites produced by the expanded members of Firmicutes, which enhanced the regeneration of damaged epithelial cells. These studies showed that heavily glycosylated IgA induced the MAFF genes that promote symbiosis via inter-phylum interactions and maintain colonic homeostasis.

What impact could this research have on humans with conditions such as inflammatory bowel disease (IBS)?

In our experiments, we treated mice with antibiotics to colonize B. theta. We observed that there were clear batch effects among the experiments for chemical-sensitive and chemical-resistant groups after the antibiotics treatment.

Image Credit: Kateryna Kon / Shutterstock

The efficient elimination of the members of Firmicutes by antibiotics enhanced the severity of the colitis, and the effect of the MAFF system was clearly observed in chemical-sensitive batches of the experiments.

I think there would be heterogeneity between our research and ulcerative colitis patients. If so, we could categorize patients into subgroups according to the composition of their gut microbiome.

The IgA-MAFF axis could be an interesting target for IBD studies in some subgroups of ulcerative colitis patients because the MAFF system is present in human colonic mucus.

We are not yet ready for human studies, but I am hopeful that our research might have an impact on IBD studies and help in the development of new treatments and/or prophylaxis for ulcerative colitis.

What are the next steps for your research?

The next step is to identify the molecular target of the MAFF system and find out how its expression is regulated along with neighboring genetic elements.

We would also like to identify and isolate the members of Firmicutes who strongly interact with B. theta via the MAFF system, would be a powerful driving force to expand our current knowledge.

It would also be interesting to tackle more details of the heterogeneity of glycosylation status of gut IgA in mice and humans. We believe that answering these questions will help us to understand the detailed mechanisms of how gut microbiota maintain equilibrium in our body.

Where can readers find more information?

About Dr. Keiichiro Suzuki

Dr. Suzuki started his career in 1996 as a clinician in a department of gastroenterology, internal medicine.

After 5 years training as a gastroenterologist, he started his scientific career as a PhD student in the laboratory of Professor Tasuku Honjo, at Kyoto University. It was in Honjo’s lab that he met Sidonia Fagarasan, who had already published many interesting papers about IgA and mucosal immunity.

Dr. Suzuki obtained a Ph.D. of medicine at Kyoto University in 2004, and soon joined Sidonia’s lab at RIKEN Yokohama Institute as a postdoctoral fellow.

His next move was to the Innovation Center for Immunoregulation Technologies and Drugs, AK project, in Kyoto University as an Associate Professor, in 2011.

In 2016, he re-joined Sidonia’s lab in the RIKEN Yokohama Institute as a senior scientist.

Tagged with:

About author

Related Articles